Omnicell CFO Nchacha Etta to step down by Sept 2025; company reiterates 2025 guidance

OMNICELL, INC.

Nchacha Etta steps down as EVP & CFO effective Sept 15, 2025 or upon successor appointment; national search underway.
Departure not due to any disagreement with the company on operations, policies, or financial reporting.
Company reiterates Q1 and full year 2025 guidance as provided on Feb 6, 2025 earnings release.
Etta will continue in role to assist transition until successor named.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nchacha Etta

Executive Vice President, Chief Financial Officer

OMCL · OMNICELL, INC.

Effective: 2025-09-15
Filed: March 12, 2025, 7:59 PM ET

On March 12, 2025, Omnicell, Inc. (the “Company”) announced that Nchacha Etta will step down from his role as Executive Vice President, Chief Financial Officer of the Company, effective September 15, 2025 or until a successor is named.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Nchacha Etta departed as Executive Vice President, Chief Financial Officer at OMNICELL, INC..

Action: will step down
Role: Executive Vice President, Chief Financial Officer

Exact text from the filing

On March 12, 2025, Omnicell, Inc. (the “Company”) announced that Nchacha Etta will step down from his role as Executive Vice President, Chief Financial Officer of the Company, effective September 15, 2025 or until a successor is named.

View on SEC.gov

OMNICELL, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-022797

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.